8.97
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALGS Giù?
Forum
Previsione
Aligos Therapeutics Inc Borsa (ALGS) Ultime notizie
Aligos Therapeutics appoints Ramon Polo as head of global regulatory affairs - TipRanks
Aligos Therapeutics appoints Ramón Polo as head of global regulatory - Investing.com
Aligos Therapeutics Appoints Ramón Polo as Senior VP, Head of Global Regulatory Affairs - Quiver Quantitative
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs - The Globe and Mail
Former J&J COVID-19 Vaccine Regulatory Leader Joins Aligos Therapeutics as Global Regulatory Head - Stock Titan
Is Aligos Therapeutics Inc. forming a bottoming baseQuarterly Market Summary & Technical Pattern Recognition Alerts - Newser
Aligos Therapeutics Inc. stock outlook for YEARJuly 2025 Spike Watch & Accurate Intraday Trade Tips - Newser
Sector ETF performance correlation with Aligos Therapeutics Inc.Weekly Risk Summary & Community Verified Trade Signals - Newser
Will Aligos Therapeutics Inc. continue its uptrendWeekly Trend Summary & Fast Gaining Stock Strategy Reports - Newser
Is Aligos Therapeutics Inc. meeting your algorithmic filter criteria2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
What data driven models say about Aligos Therapeutics Inc.’s future2025 Trading Recap & Capital Efficiency Focused Ideas - Newser
Aligos Therapeutics Inc. recovery potential after sell offJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Newser
Can volume confirm reversal in Aligos Therapeutics Inc.Bond Market & Safe Capital Growth Tips - Newser
Wall Street Analysts Predict a 983.24% Upside in Aligos Therapeutics (ALGS): Here's What You Should Know - Zacks Investment Research
Will Aligos Therapeutics Inc. stock go up soonJuly 2025 Catalysts & Community Trade Idea Sharing Platform - Newser
Can you recover from losses in Aligos Therapeutics Inc.July 2025 Breakouts & Reliable Price Breakout Alerts - Newser
Aligos Therapeutics Inc. stock momentum explainedJuly 2025 Spike Watch & Safe Entry Point Identification - Newser
Will Aligos Therapeutics Inc. stock recover after recent drop2025 Biggest Moves & AI Driven Stock Reports - Newser
Real time breakdown of Aligos Therapeutics Inc. stock performanceEarnings Risk Report & AI Forecast Swing Trade Picks - Newser
Aligos Therapeutics stock gets Buy rating from H.C. Wainwright on HBV drug potential - Investing.com India
H.C. Wainwright Assumes Coverage of Aligos Therapeutics with Buy Rating - AInvest
Aligos Therapeutics assumed with a Buy at H.C. Wainwright - TipRanks
Aligos Therapeutics receives Buy rating and $50 price target from HC Wainwright & Co. - AInvest
Does Aligos Therapeutics Inc. show high probability of reboundEarnings Overview Report & Low Risk High Win Rate Picks - Newser
Smart tools for monitoring Aligos Therapeutics Inc.’s price actionJuly 2025 Summary & Proven Capital Preservation Tips - Newser
Will Aligos Therapeutics Inc. price bounce be sustainableAnalyst Upgrade & Advanced Swing Trade Entry Plans - Newser
How Efficient Is Aligos Therapeutics Inc. at Controlling Operating CostsJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
Ranking Aligos Therapeutics Inc. among high performing stocks via tools - Newser
How to monitor Aligos Therapeutics Inc. with trend dashboardsWeekly Loss Report & Weekly Watchlist of Top Performers - Newser
Custom watchlist performance reports with Aligos Therapeutics Inc.July 2025 Sector Moves & Community Consensus Trade Alerts - Newser
Volatility clustering patterns for Aligos Therapeutics Inc.Weekly Profit Analysis & Fast Entry Momentum Alerts - Newser
News impact scoring models applied to Aligos Therapeutics Inc.2025 Institutional Moves & Daily Chart Pattern Signals - Newser
Is There Enough Volume to Lift Aligos Therapeutics Inc.Portfolio Update Report & Free Community Supported Trade Ideas - newsyoung.net
What is the dividend yield of Aligos Therapeutics Inc.2025 Trading Recap & Daily Risk Controlled Trade Plans - thegnnews.com
Is Aligos Therapeutics Inc. stock undervalued right nowWeekly Market Summary & AI Driven Price Forecasts - thegnnews.com
Using flow based indicators on Aligos Therapeutics Inc.Trade Volume Report & AI Driven Stock Reports - Newser
Using Bollinger Bands to evaluate Aligos Therapeutics Inc.July 2025 Opening Moves & Real-Time Buy Signal Alerts - Newser
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):